Greenwich LifeSciences
GLSI
19 hedge funds and large institutions have $8.9M invested in Greenwich LifeSciences in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
118% more capital invested
Capital invested by funds: $4.08M → $8.9M (+$4.82M)
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
27% more funds holding
Funds holding: 15 → 19 (+4)
1.14% more ownership
Funds ownership: 0.88% → 2.02% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.23M |
| 2 |
Millennium Management
New York
|
+$416K |
| 3 |
HF
HRT Financial
New York
|
+$373K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$368K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$253K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$107K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$58.7K |
| 3 |
SW
SkyOak Wealth
Southfield,
Michigan
|
-$23.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$19.4K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4K |
GLSI Hedge Fund Activity: Q1 2021 in Review
19 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q1 2021, worth a combined $8.9M — up 118% from $4.08M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new GLSI positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.23M. The largest seller was Bank of Montreal, exiting entirely with an estimated $107K sold.
- 19 institutional investors held Greenwich LifeSciences (GLSI) as of Q1 2021, up from 15 in Q4 2020.
- Funds reported $8.9M of Greenwich LifeSciences stock for Q1 2021, up 118% quarter-over-quarter.
- 7 funds opened new Greenwich LifeSciences positions in Q1 2021 and 3 closed out, a net change of +4 holders.
- The largest Greenwich LifeSciences buyer in Q1 2021 was Vanguard Group, an estimated $3.23M added.
- The largest Greenwich LifeSciences seller in Q1 2021 was Bank of Montreal, an estimated $107K sold.
Based on aggregated 13F filings for Q1 2021.